chr2-152135603-A-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_005843.6(STAM2):āc.705T>Cā(p.Ser235=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000564 in 1,596,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_005843.6 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STAM2 | NM_005843.6 | c.705T>C | p.Ser235= | splice_region_variant, synonymous_variant | 8/14 | ENST00000263904.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STAM2 | ENST00000263904.5 | c.705T>C | p.Ser235= | splice_region_variant, synonymous_variant | 8/14 | 1 | NM_005843.6 | P1 | |
STAM2 | ENST00000463854.5 | n.812T>C | splice_region_variant, non_coding_transcript_exon_variant | 8/11 | 1 | ||||
STAM2 | ENST00000482997.5 | n.792T>C | splice_region_variant, non_coding_transcript_exon_variant | 8/12 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000328 AC: 8AN: 244256Hom.: 0 AF XY: 0.0000228 AC XY: 3AN XY: 131770
GnomAD4 exome AF: 0.00000415 AC: 6AN: 1444244Hom.: 0 Cov.: 27 AF XY: 0.00000139 AC XY: 1AN XY: 718864
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74496
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at